Affordable Access

Access to the full text

Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients

Authors
  • Grimaldi, Antonio Maria1
  • Simeone, Ester2
  • Festino, Lucia2
  • Giannarelli, Diana3
  • Palla, Marco1
  • Caracò, Corrado4
  • Curvietto, Marcello2
  • Esposito, Assunta2
  • Grimaldi, Maria Chiara5
  • Mozzillo, Nicola4
  • Ascierto, Paolo A6
  • 1 O.U. Melanoma, Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione “G. Pascale”, Napoli, Italy , Napoli (Italy)
  • 2 O.U. Melanoma, Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione, Napoli, Italy , Napoli (Italy)
  • 3 Regina Elena National Cancer Institute, Rome, Roma, Italy , Roma (Italy)
  • 4 O.U. Melanoma and Sarcoma Surgery Istituto Nazionale Tumori di Napoli Fondazione “G. Pascale”, Napoli, Italy , Napoli (Italy)
  • 5 Catholic University of Sacred Heart, Roma, Italy , Roma (Italy)
  • 6 Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy , Naples (Italy)
Type
Published Article
Journal
Journal for ImmunoTherapy of Cancer
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Nov 04, 2015
Volume
3
Issue
Suppl 2
Identifiers
DOI: 10.1186/2051-1426-3-S2-P186
Source
Springer Nature
Keywords
License
Yellow
Report this publication

Statistics

Seen <100 times